Naltrexone Prodrugs for Transdermal Delivery
Naltrexone Prodrugs for Transdermal Delivery
批准号:
6711688
负责人:
Audra L. Stinchcomb
金额:
$25.34万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-01 至 2006-03-31
关键词:
alcoholism /alcohol abuse chemotherapycell morphologychemical propertyclinical researchcravingdiffusiondrug abuse chemotherapydrug addictiondrug adverse effectdrug design /synthesis /productiondrug metabolismendogenous opioidguinea pigshuman tissuehydrogen bondhydropathymolecular weightnaltrexonenonhuman therapy evaluationpharmacokineticsphase changephysical propertyprodrugsskinsolubilitysolventsswinetherapy compliancetransdermal drug delivery
中文摘要
纳曲酮是一种阿片类拮抗剂,目前以口服片剂的形式使用,以帮助阿片成瘾者保持无毒状态。最近,纳曲酮被表明是治疗酒精依赖的辅助药物,据报道,它还可以减少某些酗酒人群的酒精渴求。对于阿片成瘾者和酗酒者来说,纳曲酮的透皮给药是可取的,以帮助减少与口服治疗相关的副作用,并提高依从性。纳曲酮本身并不具备让治疗剂量的药物通过人体皮肤屏障所需的基本物理化学性质。我们计划继续设计和合成比纳曲酮更具皮肤渗透性的衍生物(前药),以制造治疗上成功的药物输送系统。我们假设纳曲酮前体药物将提高纳曲酮的透皮吸收速率,并且这些前体药物将成为研究透皮通量和同步代谢的定量结构-通透性关系(QSPR)的极佳研究工具。这些前体药物应该会改善纳曲酮在皮肤上的释放速度,因为它们更亲油,结晶更少,因此比纳曲酮更容易溶解。本项目的具体目标包括:(1)合成一系列纳曲酮前药,旨在阐明这些前药的透皮吸收和同时代谢的基本QSPRs;(2)表征纳曲酮前药的理化参数,包括相对分子质量、分子体积、亲脂性、氢键电位、熔点、熔化热和在选定溶剂中的溶解度;(3)测量纳曲酮前药在体外经人皮肤的渗透性和并发代谢;(4)表征纳曲酮前药在豚鼠体内的药代动力学;以及(5)表征最有希望的纳曲酮前药在豚鼠体内的药代动力学。我们的体外数据与体内模型的关联将有助于创建可靠的QSPR数据库,并有助于确定最终用于人类的最有希望的前药。
英文摘要
Naltrexone, an opioid antagonist, is currently used in oral tablet form to help maintain opioid addicts in a drug-free state. Most recently, naltrexone has been indicated as an adjunct in the treatment of alcohol dependence, as well as reported to reduce alcohol craving in certain alcoholic populations. Transdermal delivery of naltrexone is desirable for opioid addicts and alcoholics in order to help reduce side effects associated with oral therapy and improve compliance. Naltrexone itself does not have the essential physicochemical properties that would allow a therapeutic dose of the drug to cross the human skin barrier. We plan to continue designing and synthesizing derivatives (prodrugs), which are more skin permeable than naltrexone, in order to make a therapeutically successful drug delivery system. We hypothesize that prodrugs of naltrexone will improve the transdermal delivery rate of naltrexone, and that these prodrugs will make excellent research tools for investigating quantitative structure- permeability relationships (QSPRs) for transdermal flux and concurrent metabolism. These prodrugs should improve naltrexone delivery rates across the skin, because they are more lipophilic, less crystalline, and therefore more soluble than naltrexone. The specific aims of this project include: (1) to synthesize a series of naltrexone prodrugs designed to elucidate fundamental QSPRs for transdermal flux and concurrent metabolism of the prodrugs, (2) to characterize the physicochemical parameters of the naltrexone prodrugs, including molecular weight, molecular volume, lipophilicity, hydrogen-bonding potentials, melting points, heats of fusion, and solubilities in select solvents, (3) to measure the naltrexone prodrugs' penetration and concurrent metabolism through human skin in vitro, (4) to characterize the pharmacokinetics of the naltrexone prodrugs in guinea pigs in vivo, and (5) to characterize the pharmacokinetics of the most promising naltrexone prodrugs in pigs in vivo. Correlation of our in vitro data with the in vivo models will aid in the creation of a reliable QSPR database, as well as help to identify the most promising prodrug for eventual human use.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Heat Effect on Generic Transdermal Drug Delivery Systems
-
批准号:9340991
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2013
-
负责人:Audra L. Stinchcomb
-
依托单位:
Transdermal Naltrexone for Opiate Addiction and Alcoholism
-
批准号:8253142
-
项目类别:
-
资助金额:$53.78万
-
财政年份:2012
-
负责人:Audra L. Stinchcomb
-
依托单位:
Microneedle-enhanced codrug delivery for smoking cessation and appetite suppressi
-
批准号:8508902
-
项目类别:
-
资助金额:$23.01万
-
财政年份:2012
-
负责人:Audra L. Stinchcomb
-
依托单位:
Transdermal Naltrexone for Opiate Addiction and Alcoholism
-
批准号:8519709
-
项目类别:
-
资助金额:$69.6万
-
财政年份:2012
-
负责人:Audra L. Stinchcomb
-
依托单位:
Microneedle-enhanced codrug delivery for smoking cessation and appetite suppressi
-
批准号:8303925
-
项目类别:
-
资助金额:$20.36万
-
财政年份:2012
-
负责人:Audra L. Stinchcomb
-
依托单位:
Transdermal Cannabidiol Prodrug Delivery
-
批准号:8199298
-
项目类别:
-
资助金额:$16.05万
-
财政年份:2011
-
负责人:Audra L. Stinchcomb
-
依托单位:
Transdermal delivery of 2-Arachidonoyl glycerol (2-AG) for the treatment of arthr
-
批准号:8279206
-
项目类别:
-
资助金额:$7.68万
-
财政年份:2011
-
负责人:Audra L. Stinchcomb
-
依托单位:
Transdermal delivery of 2-Arachidonoyl glycerol (2-AG) for the treatment of arthr
-
批准号:8516633
-
项目类别:
-
资助金额:$5.91万
-
财政年份:2011
-
负责人:Audra L. Stinchcomb
-
依托单位:
Transdermal Cannabinoid Prodrug Treatment for Cannabis Withdrawal and Dependence
-
批准号:7943910
-
项目类别:
-
资助金额:$193.25万
-
财政年份:2009
-
负责人:Audra L. Stinchcomb
-
依托单位:
Transdermal Delivery of Buprenorphine Prodrugs
-
批准号:7611813
-
项目类别:
-
资助金额:$11.5万
-
财政年份:2009
-
负责人:Audra L. Stinchcomb
-
依托单位:
Transdermal Cannabinoid Prodrug Treatment for Cannabis Withdrawal and Dependence
-
批准号:7861337
-
项目类别:
-
资助金额:$208.07万
-
财政年份:2009
-
负责人:Audra L. Stinchcomb
-
依托单位:
Transdermal Codrugs for Treatment of Alcoholism
-
批准号:7024607
-
项目类别:
-
资助金额:$35.96万
-
财政年份:2003
-
负责人:Audra L. Stinchcomb
-
依托单位:
Transdermal Codrugs for Treatment of Alcoholism
-
批准号:6710705
-
项目类别:
-
资助金额:$36.8万
-
财政年份:2003
-
负责人:Audra L. Stinchcomb
-
依托单位:
Transdermal Codrugs for Treatment of Alcoholism
-
批准号:6865678
-
项目类别:
-
资助金额:$36.83万
-
财政年份:2003
-
负责人:Audra L. Stinchcomb
-
依托单位:
Transdermal Codrugs for Treatment of Alcoholism
-
批准号:6555545
-
项目类别:
-
资助金额:$36.67万
-
财政年份:2003
-
负责人:Audra L. Stinchcomb
-
依托单位:
Naltrexone Prodrugs for Transdermal Delivery
-
批准号:6623667
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2002
-
负责人:Audra L. Stinchcomb
-
依托单位:
Naltrexone Prodrugs for Transdermal Delivery
-
批准号:6469406
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2002
-
负责人:Audra L. Stinchcomb
-
依托单位:
Naltrexone Prodrugs for Transdermal Delivery
-
批准号:7798621
-
项目类别:
-
资助金额:$28.0万
-
财政年份:2002
-
负责人:Audra L. Stinchcomb
-
依托单位:
Naltrexone Prodrugs for Transdermal Delivery
-
批准号:6937298
-
项目类别:
-
资助金额:$6.15万
-
财政年份:2002
-
负责人:Audra L. Stinchcomb
-
依托单位:
Naltrexone Prodrugs for Transdermal Delivery
-
批准号:7597157
-
项目类别:
-
资助金额:$31.07万
-
财政年份:2002
-
负责人:Audra L. Stinchcomb
-
依托单位:
海外基金